Clinicopathological characteristics and chronology of p53 expression in the development of gastric cancer

Hepato-Gastroenterology

Volumn 60, Issue 128, 2013, Pages 2113-2118

  Karim, Sajjad ^a,b   Mirza, Zeenat ^a   Naseer, Muhammad Imran ^a   Al Qahtani, Mohammed Hussain ^a   Ali, Arif ^b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Gastric cancer; Immunohistochemistry; p53

Indexed keywords

PROTEIN P53;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP B; BLOOD GROUP O; CANCER CELL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; CARDIA; CELL DIFFERENTIATION; CHRONOLOGY; CORRELATIONAL STUDY; DIETARY INTAKE; DISEASE SEVERITY; EDUCATION; FEMALE; FISH; GENDER; GENE FUNCTION; GENE OVEREXPRESSION; GEOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MEAT; ONCOGENE; P53 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RICE; RURAL AREA; SMOKING; STOMACH ANTRUM; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH FUNDUS; TOBACCO CONSUMPTION; URBAN AREA;

ADULT; BIOPSY; CARCINOMA; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INDIA; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84893647299     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12158     Document Type: Article

References (26)

1. Parkin DM, Bray FMD, Ferlay J, et al.: Global cancer statistics. CA Cancer J Clin 2005; 55:74-108.
2. Rao DN, Ganesh B: A case-control study of stomach cancer in Mumbai, India. Int J Cancer 2002; 99:727-731. (Pubitemid 34538753)
3. Chan AO, Luk JM, Hui WM, et al.: Molecular Biology of gastric carcinoma: From laboratory to bedside. J gastroenterol Hepatol 1999; 14:1150-1160. (Pubitemid 30032952)
4. Kuerbitz SJ, Plunkett BS, Walsh WV, et al.: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sei U S A 1992; 89:7491-7495.
5. Han JA, Kim J, Ongusaha PP, et al.: p53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J 2002; 21:5635-5644. (Pubitemid 35315263)
6. Tahara E: Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993; 119:265-272.
7. Hollstein M, Sidransky D, Vogelstein B, et al.: p53 mutations in human cancers. Science 1991; 253:49-53. (Pubitemid 21917115)
8. Craanen ME, Blok P, Dekker W, et al.: Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 1995; 36:848-852.
9. Levlne AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 1991; 351:453-456.
10. Karlm S, Ali A: Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India. World J Gastroenterol 2009; 15(11):1381-1387.
11. Craanen ME, Blok P, Dekker W, et al.: Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 1995; 36:848-852.
12. Lauren P: The two histological main types of gastric carcinoma, diffuse and so-called intestinal-types carcinoma. An attempt at histochemical classification. Acta Pathol Microbiol Scand 1965; 64:31-39.
13. Tolbert DM, Noffsinger AE, Miller MA, et al.: p53 immunoreactivity and single strand conformational polymorphism analysis often fail to predict p53 mutational status. Mod Pathol 1999; 12:54-60. (Pubitemid 29059167)
14. Lane DP: The regulation of p53 function: Steiner Award Lecture. Int J Cancer 1994; 57:623-627.
15. Fukunagag M, Monden T, Nakanishi H, et al.: Immunohistochemical study of p53 in gastric carcinoma. Am J Clin Pathol 1994; 101:177-180.
16. Joupaul BV, Hopwood D, Newman EL, et al.: The prognostic significance of the accumulation of p53 tumor suppressor gene protein in gastric adenocarcinoma. Br J Cancer 1994; 69:943-946. (Pubitemid 24140680)
17. Isozaki H, Okajima K, Hu X, et al.: Multiple early gastric carcinoma, Clinicopathological features and histogenesis. Cancer 1996; 78:2078-2086. (Pubitemid 26367599)
18. Kim JH, Uhm HD, Gong SJ, et al.: Relationship between p53 overexpression and gastric cancer progression. Oncology 1997; 54:166-170. (Pubitemid 27101766)
19. Tsugane S, Sasazuki S: Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007; 10:75-83. (Pubitemid 46955941)
20. Jakszyn P, González CA: Nitrosamine and related food intake and gastric and oesophageal cancer risk: A systematic review of the epidemiological evidence. World I Gastroenterol 2006; 12:4296-4303. (Pubitemid 44194520)
21. Sinha R, Anderson DE, McDonald SS, et al.: Cancer risk and diet in India. J Postgraduate Med 2003; 49:222-228.
22. Cross AJ, Leitzmann FM, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R: A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med 2007; 4:e325.
23. Khuroo MS, Zargar SA, Mahajan R, et al.: High incidence of esophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 1992; 33:11-15.
24. Gajlakshmi CK, Shanta V: Life style and risk of stomach cancer: a hospital based case-control study. Int J Epidemiology 1996; 25:1146-1153.
25. Palli D, Caporaso NE, Shiao YH, et al.: Diet, Helicobacter pylori, and p53 mutations in gastric cancer: a molecular epidemiology study in Italy. Cancer Epidemiol Biomarkers Prev 1997; 6:1065-1069. (Pubitemid 28007418)
26. Ward MH, Lopez-Carrillo L: Dietary factor and the risk of gastric cancer in Mexico City. Am J Elidemiol 1999; 149:925392.